dazodalibep
horizon therapeutics
['dazodalibep', '#2008']
kivitz et al. phase 2 rct dazodalibep (non-antibody biologic antagonist of cd40l) in csdmard/bdmard-ir ra. improve das28-crp, cdai, sdai, tjc, sjc at day 113. #acr22 abstr#2008 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC